I don't think we can expect to get by without further cap raises. But this will help to space them out a bit and potentially reduce the amount required.
This is an extension of the 43.5% R&D expenditure rebate from that conducted in Oz to all R&D expenditure.
So for the next $100m we spend on R&D, regardless of where it is carried out, we'll get $44m in rebates.
Best thing is we don't need to limit trials and pre-clinical work to Oz to secure R&D rebates. Very cool.
Credit to James and the team. Surely there are more sources of non-dilutive funding available, given the seriousness of the public health issue Recce is seeking to address.
.![]()
- Forums
- ASX - By Stock
- RCE
- Ann: RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
Ann: RCE Awarded $43.7m AusIndustry Advanced Overseas Finding, page-12
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
59.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.3M |
Open | High | Low | Value | Volume |
59.0¢ | 59.5¢ | 57.0¢ | $85.59K | 145.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 9864 | 57.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.5¢ | 38611 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 9864 | 0.570 |
1 | 15000 | 0.565 |
4 | 32423 | 0.560 |
1 | 901 | 0.555 |
1 | 1441 | 0.550 |
Price($) | Vol. | No. |
---|---|---|
0.595 | 38611 | 2 |
0.600 | 50611 | 3 |
0.605 | 27961 | 2 |
0.650 | 76700 | 2 |
0.655 | 6970 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online